For instance, an increasing trend in percent CGM time >7.8 mmol/L (140 mg/dL) might be expected in a cohort of children with presymptomatic type 1 diabetes if all are progressing toward clinical onset at, albeit, a variable rate, which would result in high within-person variability in serial measurements.
← all excerpts
Longitudinal Continuous Glucose Monitoring Study in Young Children With Presymptomatic Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) At-Risk Cohort Study.
1
—
—